In this phase 3, double-blind, randomized, placebo-controlled trial, we used a 2-by-3 factorial design to test the effectiveness of three repurposed drugs — metformin, ivermectin, and ...

With fluvoxamine, doctors find an old drug that may actually work against COVID-19 Medical students and staff members of a Houston hospital prepare for a shift dealing with COVID-19 patients ...

Topline Fluvoxamine, a cheap and widely available pill used around the world to treat mental illness, is very likely to reduce the risk of being hospitalized with Covid-19, according to new peer ...

Researchers hailed fluvoxamine — which is normally used to treat obsessive-compulsive disorder — for its “safety, tolerability, ease of use, low cost, and widespread availability.” ...

The antidepressant drug fluvoxamine, sold under the name Luvox, prevented serious complications in COVID-19 patients who chose to take it. In comparison, some people who did not take the ...

A safe, well-established antidepressant pill has proven effective at heading off severe COVID-19 cases, recent studies indicate. Fluvoxamine dramatically reduced the risk of hospitalization for ...

Fluvoxamine vs. placebo and clinical deterioration in outpatients with symptomatic COVID 19: a randomized clinical trial. JAMA, Nov. 12, 2020.

A cheap, generically available anti-depressant may reduce the risk of severe Covid-19 disease by close to a third in people at high risk, researchers reported Wednesday.

The FDA released a document with information about its decision to not authorize fluvoxamine to treat COVID-19. It’s unusual for the agency to publicize its reasoning for rejecting a drug.

Stewart TG, Rebolledo PA, Mourad A, et al. Higher-dose fluvoxamine and time to sustained recovery in outpatients with COVID-19: The ACTIV-6 Randomized Clinical Trial.